Dual Antiplatelet Therapy in Coronary Artery Disease

Abstract Acute coronary syndrome (ACS) is principally driven by platelet aggregation. Dual antiplatelet therapy (DAPT) has demonstrated a reduction in recurrent ischemic events. The newer antiplatelets ticagrelor and prasugrel have demonstrated superiority over clopidogrel. While prasugrel demonstra...

Full description

Bibliographic Details

Published in:	Cardiology and Therapy
Main Authors:	Raghav Sharma, Prathap Kumar, S. P. Prashanth, Yogesh Belagali
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2020-08-01
Subjects:	Clopidogrel Coronary artery disease Dual antiplatelet therapy Prasugrel Switching between antiplatelets Ticagrelor
Online Access:	https://doi.org/10.1007/s40119-020-00197-0